Explore the intricate connection between the endocannabinoid system (ECS), its expanded version – the endocannabinoidome (eCBome), and Parkinson’s disease (PD). The article delves into the potential of these systems as novel therapeutic targets for PD, offering fresh insights into ongoing research and future treatment possibilities.
Delve into the neuroprotective role of the Endocannabinoid System (ECS) in the brain, with particular emphasis on CB1 and CB2 cannabinoid receptors. This comprehensive review covers the ECS’s crucial role in neuronal protection against trauma, ischemia, neuroinflammation, and neurodegeneration. Additionally, learn about the potential therapeutic implications of various endogenous neuroprotective compounds that interact with the ECS.